Novel Spiro-Oxindole Synthesis via Cascade Reaction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for developing antitumor agents face challenges in accessing diverse variants of octahydroindolo[2,3-a]quinolizine monoterpene indole alkaloids in a completely diastereo-controlled, step-economic, and atom-economic manner, and in modulating mitochondrial functions effectively for cancer therapy.

Innovation Solution

A novel one-pot practical and modular approach is introduced to access diversely functionalized heterocyclic systems with more than three contiguous chiral centers through desymmetrization of oxidative dearomatization products of phenols, followed by a formal Pictet-Spengler/Aza-Michael addition cascade, which are then transformed into spiro-oxindole systems.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional multi-step stereoselective methods are used to synthesize octahydroindolo[2,3-a]quinolizine monoterpene indole alkaloids, then diastereo-control can be achieved, but the synthesis process becomes complex and time-consuming

Engineering Contradiction:
Improvediastereo-controlVSAvoidsynthesis process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent combines multiple reaction steps (oxidative dearomatization, Pictet-Spengler cyclization, and Aza-Michael addition) into a one-pot cascade reaction. This merging of steps eliminates intermediate isolation and purification, reducing process complexity while maintaining diastereo-control through the inherent stereoselectivity of each transformation in the cascade sequence.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent employs preliminary protection of the indole nitrogen and strategic placement of functional groups in the starting phenol substrate. These preliminary arrangements enable the cascade reaction to proceed with high diastereo-control by pre-positioning reactive sites that will form the stereocenters in a predictable manner during the cascade process.

Inventive Principle:
Principle #10Preliminary action

2Adaptability or versatility

If multiple reaction steps are used to access diverse variants of monoterpene indole alkaloids, then structural diversity can be achieved, but the number of steps increases reducing efficiency

Engineering Contradiction:
Improvestructural diversityVSAvoidsynthesis efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent develops a universal one-pot cascade protocol that can access diverse variants of octahydroindolo[2,3-a]quinolizine monoterpene indole alkaloids from different phenol substrates. The same reaction conditions (oxidative dearomatization followed by Pictet-Spengler/Aza-Michael cascade) apply across multiple substrates, enabling structural diversity without requiring different synthetic routes for each variant.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent segments the synthesis into a modular cascade where the oxidative dearomatization step generates diverse intermediate structures that then converge into the Pictet-Spengler/Aza-Michael cyclization sequence. This segmentation allows diverse substrates to be processed through the same downstream steps, maintaining efficiency while achieving diversity.

Inventive Principle:
Principle #1Segmentation

3Productivity

If step-economic synthesis methods are employed, then the number of steps is reduced, but achieving complete diastereo-control becomes more difficult

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoiddiastereo-control
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The cascade reaction is designed to be self-service in terms of stereosecontrol. The oxidative dearomatization step generates intermediates with inherent stereochemical bias that directs the subsequent Pictet-Spengler and Aza-Michael additions. Each step in the cascade serves to establish or reinforce the stereochemistry set by previous steps, eliminating the need for external chiral auxiliaries or catalysts while maintaining complete diastereo-control.

Inventive Principle:
Principle #25Self-service

4Loss of substance

If atom-economic reactions are used, then waste is minimized, but the complexity of designing such reactions increases

Engineering Contradiction:
Improvewaste minimizationVSAvoidreaction design complexity
Core Design Contradiction:
Loss of substanceVSDevice complexity

Solution Approach 1:

The patent employs continuous useful action through the cascade mechanism where the product of one reaction step immediately serves as the substrate for the next step without isolation. The oxidative dearomatization generates an intermediate that is directly consumed by the Pictet-Spengler cyclization, which in turn produces the substrate for the Aza-Michael addition. This continuous transformation minimizes waste and eliminates the need for complex purification steps between reactions.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the synthesis of compounds with enhanced effects on mitochondrial and cellular functions, effectively modulating cellular metabolism to inhibit cancer cell proliferation and survival, while maintaining immunological function.

Implementation Method 1

measuring the ATP content, the mitochondrial membrane potential and the cellular redox potential

Methodology Applied
Scientific EffectMitochondrial membrane potential:

Implementation Method 2

measuring the ATP content, the mitochondrial membrane potential and the cellular redox potential

Methodology Applied
Scientific EffectRedox potential: Redox Reactions

Data Source

PatentUS12269821B2Discovery of novel first in class nature-inspired compounds targeting the mitochondrial function and pharmaceutical composition thereof
Publication Date: 2025.04.08 UNIVERSITY OF SHARJAH
  • US12269821B2 patent drawing
  • US12269821B2 patent drawing
  • US12269821B2 patent drawing

AI summary

The present invention relates to novel antitumor agents and pharmaceutically acceptable salts thereof, processes and intermediates for the manufacture of these novel constrained cyclic frameworks of general formula I and II, and medicaments containing such compounds.